Jubilant Life Sciences shines on raising Rs 350 crore via NCDs

07 Sep 2018 Evaluate

Jubilant Life Sciences is currently trading at Rs. 823.60, up by 63.35 points or 8.33% from its previous closing of Rs. 760.25 on the BSE.

The scrip opened at Rs. 760.00 and has touched a high and low of Rs. 830.00 and Rs. 758.75 respectively. So far 144644 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1039.00 on 08-Feb-2018 and a 52 week low of Rs. 600.00 on 25-Oct-2017.

Last one week high and low of the scrip stood at Rs. 830.00 and Rs. 728.00 respectively. The current market cap of the company is Rs. 12998.93 crore.

The promoters holding in the company stood at 50.68%, while Institutions and Non-Institutions held 29.30% and 20.02% respectively.

Jubilant Life Sciences has raised Rs 350 crore through non-convertible debentures (NCDs) on private placement basis. The company has issued 3,500 NCDs of Rs 10 lakh each for cash at par on September 5, 2018. NCDs are proposed to be listed on National Stock Exchange of India.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.

Jubilant Pharmova Share Price

954.65 -13.60 (-1.40%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×